NMTR News and Press, 9 Meters Biopharma Inc. From 12/07/20

-Rapid onset and sustained clinical effect following first dose in all 9 patients in total stool output (TSO) volume -Clinically relevant improvements in TSO volume and bowel movement frequency -Twice-monthly fixed-dosing regimen exhibited an excellent safety and tolerability profile -Plan t...

Gainers: Sundial Growers (SNDL) +35%, FSD Pharma (HUGE) +32%, Apollo Endosurgery (APEN) +26%, G1 Therapeutics (GTHX) +23%, Oncolytics Biotech (ONCY) +17%.Losers: SCWorx (WORX) -14%, 9 Meters Biopharma (NMTR) -14%, AnPac Bio-Medical Science (ANPC)&#...

Are These ON Your List Of Penny Stocks To Watch Right Now? Whether you’re looking for penny stocks to buy or just a few to watch, it’s important to keep your trading strategy in mind. With the way that the market has been trading, there’s a lot of bullish exuber...

Are These Biotech Penny Stocks On Your List Right Now? Are you looking for top biotech penny stocks after seeing Moderna stock skyrocket this week? Shares of MRNA stock jumped over 10% in a single day. However, the sympathy trade is what others were looking at. What I’m talki...

NM-102, a novel next-generation microbiome modulator, shows positive effect in an aggressive immune checkpoint inhibitor failure melanoma model IND-enabling planning underway RALEIGH, NC / ACCESSWIRE / November 16, 2020 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical...

These Biotech Penny Stocks Continue Seeing Positive Sentiment As the latest news suggests, rising Covid cases means more attention is being paid to biotech penny stocks . These low priced stocks have become some of the most intriguing investments during the year. While they can be q...

Phase 1b/2a Trial With a Proprietary Long-Acting GLP-1 Agonist in Short Bowel Syndrome Top-Line Data Expected in Q4 Continued Enrollment of Phase 3 Trial Larazotide in Celiac Disease, Interim Analysis Remains on Target for 1H 2021 RALEIGH, NC / ACCESSWIRE / November 9, 2020 / 9 M...

- H.C. Wainwright Annual Israel Conference - November 12 th - A.G.P. Virtual Healthcare Symposium 2020 - November 19 th RALEIGH, NC / ACCESSWIRE / November 2, 2020 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage rare and unmet needs-focused gastroenterology company an...

The following healthcare companies have filed for mixed shelf offerings:Agile Therapeutics (AGRX): $200M.9 Meters Biopharma (NMTR): $200M.Sintx Technologies (SINT): $75M. For further details see: Mixed shelf roundup - healthcare

William Blair initiates coverage on $95M market cap 9 Meters Biotech (NMTR), saying its pipeline is a "blockbuster in the making."The current Phase 3 study of larazotide should show results in Q4 of 2021, says Blair, and, if positive, the company will file for conditional approval in the U.S....